Article Details

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a ...

Retrieved on: 2023-01-07 02:01:04

Tags for this article:

Click the tags to see associated articles and topics

Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a .... View article details on HISWAI: https://pipelinereview.com/index.php/2023010682428/Antibodies/Alvotech-and-Teva-Announce-Acceptance-of-U.S.-Biologics-License-Application-for-AVT04-a-Proposed-Biosimilar-to-Stelara-ustekinumab.html

Excerpt

Details: Category: Antibodies: Published on Friday, 06 January 2023 ... AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara® ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up